Analyst Ratings for Gossamer Bio Inc. (GOSS)
GOSS Rating Summary
GOSS Price Target Summary
- Highest: $160.00 (Chardan)
- Lowest: $0.28 (Barclays)
- Average: $32.47
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$32.47 (+237.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$32.47 (+237.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Chardan | Andreas Argyrides | New Coverage | Buy (N/A) |
160.00 (N/A) |
9.31 (9.61) |
3.22% | Details |
| 7/28/2026 | Leerink | Joseph Schwartz | Upgrade | Outperform (Market Perform) |
1.00 (N/A) |
0.14 (9.61) |
6764.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
